The American Journal of Medicine
Volume 120, Issue 5 , Pages 461.e11-461.e17 , May 2007

Hyponatremia in Marathon Runners due to Inappropriate Arginine Vasopressin Secretion

  • Arthur J. Siegel, MD

      Affiliations

    • Department of Medicine, McLean Hospital, Belmont, Mass
    • Harvard Medical School, Boston, Mass
  • ,
  • Joseph G. Verbalis, MD

      Affiliations

    • Department of Medicine, Georgetown University Medical Center, Washington, DC
  • ,
  • Stephen Clement, MD

      Affiliations

    • Department of Medicine, Georgetown University Medical Center, Washington, DC
  • ,
  • Jack H. Mendelson, MD

      Affiliations

    • Department of Medicine, McLean Hospital, Belmont, Mass
    • Harvard Medical School, Boston, Mass
  • ,
  • Nancy K. Mello, PhD

      Affiliations

    • Department of Medicine, McLean Hospital, Belmont, Mass
    • Harvard Medical School, Boston, Mass
  • ,
  • Marvin Adner, MD

      Affiliations

    • Metrowest Medical Center, Framingham, Mass
  • ,
  • Terry Shirey, PhD

      Affiliations

    • Nova Biomedical Inc, Waltham, Mass
  • ,
  • Julie Glowacki, PhD

      Affiliations

    • Department of Orthopedics, Brigham and Women's Hospital
    • Harvard Medical School, Boston, Mass
  • ,
  • Elizabeth Lee-Lewandrowski, PhD

      Affiliations

    • Division of Laboratory Medicine, Department of Pathology, Massachusetts General Hospital, Boston, Mass.
    • Harvard Medical School, Boston, Mass
  • ,
  • Kent B. Lewandrowski, MD

      Affiliations

    • Metrowest Medical Center, Framingham, Mass
    • Harvard Medical School, Boston, Mass
    • Corresponding Author InformationRequests for reprints should be addressed to Kent B. Lewandrowski, MD, Clinical Chemistry, Gray 5, Massachusetts General Hospital, Fruit Street, Boston, MA 02114.

References 

  1. Almond CS, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005;352:1550–1556
  2. Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–714
  3. Davis DP, Videen JS, Marino A, et al. Exercise-associated hyponatremia in marathon runners: a two-year experience. J Emerg Med. 2001;21:47–57
  4. Hew TD, Chorley JN, Cianca JC, Divine JG. The incidence, risk factors and clinical manifestations of hyponatremia in marathon runners. Clin J Sports Med. 2003;13:41–47
  5. Kratz A, Siegel AJ, Verbalis JG, et al. Sodium status of collapsed marathon runners. Arch Pathol Lab Med. 2005;129:227–230
  6. Goudie AM, Tunstall-Pedoe DS, Kerins M, Terris J. Exercise-associated hyponatraemia after a marathon. J R Soc Med. 2006;99(7):363-367.
  7. Hew T, Almond C, Ayus JC, et al. Consensus Statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clin J Sports Med. 2005;15:208–213
  8. Siegel AJ, Steck JJ, Lipinska I, et al. Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol. 2001;88:35–37
  9. Kratz A, Lewandrowski KB, Siegel AJ, et al. Effect of marathon running on hematological and biochemical laboratory parameters including cardiac markers. Am J Clin Pathol. 2002;118:856–863
  10. Saenz AJ, Lee-Lewandrowski E, Wood MJ, et al. Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon. Am J Clin Pathol. 2006;126:1–5
  11. Suzuki K, Yamada M, Kurakake S, et al. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol. 2000;81:281–287
  12. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology. 2001;26:761–788
  13. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 2002;16:1335–1347
  14. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42:790–806
  15. Stricker EM, Verbalis JG. Interaction of osmotic and volume stimuli in the regulation of neurohypophyseal secretion of rats. Am J Physiol Regul Integr Comp Physiol. 1986;250:R267–R275
  16. Miaskiewicz SL, Stricker EM, Verbalis JG. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans. J Clin Endocrinol Metab. 1989;68:837–843
  17. Noakes TD, Goodwin N, Rayner BL, et al. Water intoxication: a possible complication during endurance exercise. Med Sci Sports Exerc. 1985;17:370–375
  18. Frizzell RH, Lang GH, Lathan R. Hyponatremia and ultramarathon running. JAMA. 1986;255:772–774
  19. Hiller WDB. Dehydration and hyponatremia during triathlons. Med Sci Sports Exerc. 1989;21:219–221
  20. Speedy DB, Rogers IR, Noakes TD, et al. Exercise-induced hyponatremia in ultradistance triathletes is caused by inappropriate fluid retention. Clin J Sport Med. 2000;10:272–278
  21. Verbalis JG. The syndrome of inappropriate antidiuretic hormone secretion and other hypo-osmolar disorders. In:  Schrier RW editors. Diseases of the Kidney and Urinary Tract. 7th ed.. Philadelphia: Lippincott Williams & Wilkins; 2001;p. 2511–2548
  22. Kawai N, Baba A, Suzuki T, Shiraishi H. Roles of arginine vasopressin and atrial natriuretic peptide in polydipsia-hyponatremia of schizophrenic patients. Psychiatry Res. 2001;101:39–45
  23. Feldman BJ, Rosenthal SM, Vargas GA, et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005;352:1884–1890
  24. Noakes TD. Over-consumption of fluids by athletes. BMJ. 2003;327:113–114
  25. Noakes TD, Speedy DB. Case proven: exercise associated hyponatremia is due to overdrinking. So why did it take 20 years for the original evidence to be accepted? Br J Sports Med. 2006;40:567-572.
  26. Leaf A, Bartter FC, Santos RF, Wrong O. Evidence in man that urinary electrolyte loss induced by Pitressin is a function of water retention. J Clin Invest. 1953;32:868–876
  27. Verbalis JG. Whole-body volume regulation and escape from antidiuresis. Am J Med. 2006;119(7A):S21-S29.
  28. Soares TJ, Coimbra TM, Martins AR, et al. Atrial natriuretic peptides and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci U S A. 1999;96:278–283
  29. Wadyka S. New rules of hydration: revisionist drinking. Runner's World. 2006; Aug: 68-70.
  30. Guidelines to help prevent both dehydration and hyponatremia in this year's Boston marathon. Gatorade Sports Science Institute. http//www.itsonthecourse.com http://gssiweb.org2006;Accessed April 16
  31. Nolph KD, Schrier RW. Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med. 1970;49:534–545
  32. Swanka MN, Burke LM, Eichner ER. Exercise and fluid replacement. Position stand, Am College of Sports Medicine. Med Sci Sports Exerc. 2007;39:377–390
  33. Goldman MB, Nash M, Blake L, Petrovic MS. Do electrolyte-containing beverages improve water balance in hyponatremic schizophrenics?. J Clin Psychiatry. 1994;55:151–153
  34. Twerenbold R, Knechtle B, Kakebeeke TH, et al. Effects of different sodium concentrations in replacement fluids during prolonged exercise in women. Br J Sports Med. 2003;37:300–303
  35. Dugas JP, Noakes TD. Case report: hyponatraemic encephalopathy despite a modest rate of fluid intake during a 109 km cycle race. Br J Sports Med. 2005; 39:e38. Available at: http://bjsm.bmjjournals.com/cgi/content/abstract/39/10/e38?maxtoshow = &HITS = 10&hits = 10&RESULTFORMAT = &author1 = dugas&andorexactfulltext = and&searchid = 1130785119960_3707&stored_search = &FIRSTINDEX = 0&sortspec = relevance&volume = 39&resourcetype = 1&journalcode = bjsports. Accessed December 1, 2005.
  36. Dugas J. Sodium ingestion and hyponatraemia: sports drinks do not prevent a fall in serum sodium concentration during exercise. Br J Sports Med. 2005; Available at: http://bjsm.bmjjournals.com/cgi/content/abstract/39/10/e38?maxtoshow = &HITS = 10&hits = 10&RESULTFORMAT = &author1 = dugas&andorexactfulltext = and&searchid = 1130785119960_3707&stored_search = &FIRSTINDEX = 0&sortspec = relevance&volume = 39&resourcetype = 1&journalcode = bjsports. Accessed December 1, 2005.
  37. Hew-Butler T, Verbalis JG, Noakes TD. Updated fluid recommendations: position statement from the International Marathon Medical Directors Association (IMMDA). Clin J Sports Med. 2006;16:283–292
  38. Running USA-RRIC annual marathon reports. http://www.runningusa.org/cgi/mar_repts.pl2005;Accessed December 6
  39. Weschler LB. Exercise-associated hyponatremia: a mathematical review. Sports Med. 2005;35:899–922
  40. Garcia EBG, Ruitenberg A, Madretsma GS, Hintzen RQ. Hyponatraemic coma induced by desmopressin and ibuprofen in a woman with von Willebrand's disease. Haemophilia. 2003;9:232–234
  41. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459–481
  42. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471–503
  43. Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant. 2003;18:2486–2491
  44. Nzerue CM, Baffoe-Bonnie H, You W, et al. Predictors of outcome in hospitalized patients with severe hyponatremia. J Natl Med Assoc. 2003;95:335–343
  45. Androgue HJ. Consequences of inadequate management of hyponatremia. Am J Nephrol. 2005;25:240–249
  46. Verbalis JG. Adaptation to acute and chronic hyponatremia: implications for symptomatology, diagnosis, and therapy. Semin Nephrol. 1998;18:3–19
  47. Stearns RH, Silver SM. Brain volume regulation to hypo-osmolality and its correction. Am J Med. 2006;119(7A):S12-S16.
  48. Alam NH, Yunus M, Faruque ASG, et al. Symptomatic hyponatremia during treatment of dehydrating diarrheal disease with reduced osmolarity oral rehydration solution. JAMA. 2006;296:567–573
  49. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. 1994;79:934–939
  50. Siegel AJ. Exercise-associated hyponatremia: role of cytokines. Am J Med. 2006;119(7A):S87-S92.
  51. Chikanza IC, Petrou P, Chrousos G. Perturbations of arginine vasopressin secretion during inflammatory stress (Pathophysiologic implications). Ann NY Acad Sci. 2000;917:825–834
  52. Beukhof CM, Hoorn EJ, Lindemans J, Zeitse R. Novel risk factors for hospital-acquired hyponatremia: a matched case-control study. Clin Endocrinol. 2007;66:367-372.
  53. Noakes TD, Sharwood K, Speedy D, et al. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci USA. 2005;102:18550–18555
  54. Montain SJ, Cheuvront SN, Sawka MN. Exercise associated hyponatremia: quantitative analysis to understand the etiology. Br J Sports Med. 2006;40:98–105
  55. Rosner MH, Kirven J. Exercise-associated hyponatremia. In-depth review. Clin J Am Soc Nephrol. 2007;2:151-161.
  56. Bennermo M, Held C, Stemme S, Ericsson CG, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases. Clin Chem. 2004;50:2136–2140
  57. Verbalis JG. Vasopressin V2 receptor antagonists. J Mol Endocrinol. 2002;29:1–9
  58. Palm C, Pistrosch F, Herbrig K, Gross P. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Am J Med. 2006;119(7A):S87-S92.
  59. Munger MA. New agents for managing hyponatremia in hospitalized patients. Am J Health-Syst Pharm. 2007;64:253-65.

 Supported in part by grants KO5-DA00064, KO5-DA00101, and POI-DA14528 from National Institute on Drug Abuse, and by grant M01-RR 020359 from the National Center for Research Resources, National Institutes of Health.

PII: S0002-9343(07)00167-2

doi: 10.1016/j.amjmed.2006.10.027

The American Journal of Medicine
Volume 120, Issue 5 , Pages 461.e11-461.e17 , May 2007